drugset / Trial / NCT01980199

Trial to Determine Efficacy of Fexinidazole in Visceral Leihmaniasis Patients in Sudan

NCT01980199

Phase 2 Terminated 14 enrolled Drugs for Neglected Diseases
NaSingle-groupOpen-labelTreatment

Summary

This study is designed to determine the efficacy of Fexinidazole as an oral treatment in Visceral Leishmanisasis sudanese adults patients. The results of this proof of concept study will allow to make a decision on whether to proceed with clinical development of Fexinidazole for visceral leishmaniasis.

Timeline

Start
2013-11
Primary completion
2014-11
Completion
2015-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Fexinidazole Small molecule 1200 mg Oral